OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis
Qian Sun, Hongyan Sun, Nan Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Qian Sun, Hongyan Sun, Nan Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Showing 6 citing articles:
Association of the CD4+/CD8+ ratio with response to PD-1 inhibitor-based combination therapy and dermatological toxicities in patients with advanced gastric and esophageal cancer
Shuangwei Xu, Qiuwei Zhu, Lixia Wu, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110642-110642
Open Access | Times Cited: 16
Shuangwei Xu, Qiuwei Zhu, Lixia Wu, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110642-110642
Open Access | Times Cited: 16
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment
Yaxin Du, Wenjie Wu, Mei Chen, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 10, pp. 1093-1093
Open Access | Times Cited: 15
Yaxin Du, Wenjie Wu, Mei Chen, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 10, pp. 1093-1093
Open Access | Times Cited: 15
Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma – An analysis of the prospective skin cancer registry ADOREG
Corinna Kochanek, Catharina Gilde, Lisa Zimmer, et al.
European Journal of Cancer (2023) Vol. 198, pp. 113508-113508
Open Access | Times Cited: 4
Corinna Kochanek, Catharina Gilde, Lisa Zimmer, et al.
European Journal of Cancer (2023) Vol. 198, pp. 113508-113508
Open Access | Times Cited: 4
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study
Stine K. Christensen, Mette Lerche Winther, Ida J. Laursen, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 5
Open Access
Stine K. Christensen, Mette Lerche Winther, Ida J. Laursen, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 5
Open Access
Cytomegalovirus infection protects against metastatic melanoma and modulates oncological outcome and toxicity to checkpoint immunotherapy
Gusztav Milotay, Martin Little, Robert Watson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Gusztav Milotay, Martin Little, Robert Watson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Association of the CD4+ /CD8+ ratio with response to PD-1 inhibitor-based combination therapy and dermatologic toxicities in patients with advanced gastric and esophageal cancer
Shuangwei Xu, Lixia Wu, Qiuwei Zhu, et al.
Research Square (Research Square) (2022)
Open Access
Shuangwei Xu, Lixia Wu, Qiuwei Zhu, et al.
Research Square (Research Square) (2022)
Open Access
